INSIGHTS ON DRUG DEVELOPMENT
-
3D Neurospheres In Healthy And Alzheimer's: iPSC-Derived Neurons
Explore how different ApoE alleles influence Alzheimer's Disease risk using iPSC-derived neurons as well as gain insights into AD mechanisms and potential therapies.
-
Solving Bioavailability Challenges In bRo5 Drugs
Leverage mechanistic, material-sparing formulation strategies to enhance bioavailability and accelerate development of challenging bRo5 small molecules, even with limited resources.
-
Screening For Amorphous Drug Substance
Incorporate amorphous form screening early in development to unlock solubility advantages, improve bioavailability, and accelerate your path to market.
-
Precision By Design: Drug Innovation Through Structure-Based Drug Design (SBDD)
Leverage structure-based drug design to gain deeper molecular insights, prioritize high-potential candidates, and accelerate your path from discovery to clinic.
-
Small Molecule Orphan Drugs: Status Quo, Challenges, And Perspectives3/11/2026
By establishing robust manufacturing processes and scalable production strategies from the outset, developers can help de-risk orphan drug production, improve efficiency, and position their programs for greater long-term success.
-
Overcoming Challenges In Ophthalmic Formulations8/27/2025
Discover key strategies for overcoming formulation challenges in ophthalmic drug development and learn how selecting the right excipients supports quality, compliance, and safety.
-
Enhance Cell Line Development With Rapid Whole-Well Imaging11/7/2025
Whole-well imaging streamlines clone selection by enabling rapid, automated analysis of single-cell growth and morphology, which reduces manual effort and improves reproducibility.
-
5 Key Considerations For Companies Outsourcing Process Development6/9/2025
Venture capital in biotech remains strong post-pandemic, especially in cell and gene therapies. Discover five key factors to help companies choose between in-house and outsourced process development strategies.
-
Accelerated Yield Optimization Of Affinity Capture5/15/2026
High‑throughput affinity screening shows how buffer and pH optimization can boost AAV5 recovery, enabling faster, more reliable downstream process development for challenging serotypes.
DRUG DEVELOPMENT SOLUTIONS
-
Waters MaxPeak Premier Columns and Solutions dramatically reduce NSA with MaxPeak High Performance Surfaces, innovative technologies designed to reduce analyte loss due to analyte/surface interactions.
-
One MS Software for All Your Mass Spectral Data Analysis and Management
ACD/MS Workbook Suite is an all-in-one package for MS data handling.
- Process MS, LC/MS, and GC/MS data acquired with instruments from any major vendor
- Auto-annotate peaks and associate them with compound structures
- Identify unknowns by deconvoluting spectra and searching databases for spectral matches
- Create easily shareable and searchable spectral databases
-
Nanoform’s proprietary bionanoparticle technology can deliver large-molecule drug particles as small as 50 nm while retaining biological activity. This can not only enable more patient-friendly approaches to drug delivery, but also potentially higher loads of active ingredients.
-
Discover a system with a flexible synthesis scale, intuitive software, and robust process control that is ideal for labs moving from research to production.
-
STELLARIS 8 CRS Coherent Raman Scattering Microscope
When you need to study structures that cannot be visualized with traditional fluorescent microscopy methods, the STELLARIS 8 Coherent Raman Scattering (CRS) microscope enables you to implement label-free chemical imaging into your workflow to answer those challenging research questions.